Mitigating the Impact of COVID-19 on Oncology: Clinical and Operational Lessons from a Prospective Radiation Oncology Cohort Tested for COVID-19

Since its outbreak in December 2019 [1], the novel coronavirus (SARS –CoV-2) and associated respiratory disease (COVID-19) have led to a global pandemic, adversely impacting healthcare across the world [2]. The field of oncology faces particular challenges, as reports from Wuhan indicate that cancer patients are more vulnerable to COVID-19 and carry a greater risk of morbidity and death [3]. These data are corroborated by reports from Italy [4–6], in which radiotherapy (RT) departments have also been impacted [7,8], and data from New York City [9].

Source: Radiotherapy and Oncology - May 27, 2020 Category: Radiology Authors: Matthew S. Ning, Mary Frances McAleer, Melenda D. Jeter, Bruce D. Minsky, Robert A. Ghafar, Ivy J. Robinson, Paige L. Nitsch, Denise J. Zaebst, Sarah E. Todd, Jennifer Nguyen, Steven H. Lin, Zhongxing Liao, Percy Lee, G. Brandon Gunn, Ann H. Klopp, Boutha Tags: COVID-19 Rapid Communication Source Type: research